What Is Vision Rehabilitation Following Brain Injury?

2011 ◽  
pp. 1-30 ◽  
Author(s):  
Penelope Suter ◽  
Lynn Hellerstein ◽  
Lisa Harvey ◽  
Katharina Gutcher
2019 ◽  
Vol 30 (1) ◽  
pp. 171-188 ◽  
Author(s):  
Sandra M. Fox ◽  
Paul Koons ◽  
Sally H. Dang

2020 ◽  
Vol 87 (2) ◽  
pp. 117-126
Author(s):  
Paul Y. Yoo ◽  
Katryne Scott ◽  
Filip Myszak ◽  
Stephanie Mamann ◽  
Amelie Labelle ◽  
...  

Background. The existing literature on the effectiveness of interventions targeting vision, visual-perceptual impairments following acquired brain injury (ABI) is scarce and unlinked to occupational performance. Purpose. To explore current occupational therapy practice in vision-rehabilitation among adults with ABI in Canada, and to determine the evidence-practice gaps. Methods. An online survey was made available through the Canadian Association of Occupational Therapists (CAOT) website, and disseminated to seven public healthcare institutions in Quebec. The survey collected respondent demographic information, and the types and frequency of treatments delivered. Descriptive statistics were conducted to determine interventions’ frequency. Participant comments were collected and grouped into recurring themes. Findings. Over half (55%) of respondents regularly use evidence-based interventions when addressing visual acuity (VA) and visual field (VF) deficits, but only very few (3%) use it when dealing with oculomotor function and visual stress impairments. Implications. Results gave a glimpse of interventions used and suggested the need for further research in vision rehabilitation.


2017 ◽  
Author(s):  
Rune Skovgaard Rasmussen ◽  
Anne Marie Heltoft Schaarup ◽  
Karsten Overgaard

BACKGROUND Serious and often lasting vision impairments affect 30% to 35% of people following stroke. Vision may be considered the most important sense in humans, and even smaller permanent injuries can drastically reduce quality of life. Restoration of visual field impairments occur only to a small extent during the first month after brain damage, and therefore the time window for spontaneous improvements is limited. One month after brain injury causing visual impairment, patients usually will experience chronically impaired vision and the need for compensatory vision rehabilitation is substantial. OBJECTIVE The purpose of this study is to investigate whether rehabilitation with Neuro Vision Technology will result in a significant and lasting improvement in functional capacity in persons with chronic visual impairments after brain injury. Improving eyesight is expected to increase both physical and mental functioning, thus improving the quality of life. METHODS This is a prospective open label trial in which participants with chronic visual field impairments are examined before and after the intervention. Participants typically suffer from stroke or traumatic brain injury and will be recruited from hospitals and The Institute for the Blind and Partially Sighted. Treatment is based on Neuro Vision Technology, which is a supervised training course, where participants are trained in compensatory techniques using specially designed equipment. Through the Neuro Vision Technology procedure, the vision problems of each individual are carefully investigated, and personal data is used to organize individual training sessions. Cognitive face-to-face assessments and self-assessed questionnaires about both life and vision quality are also applied before and after the training. RESULTS Funding was provided in June 2017. Results are expected to be available in 2020. Sample size is calculated to 23 participants. Due to age, difficulty in transport, and the time-consuming intervention, up to 25% dropouts are expected; thus, we aim to include at least 29 participants. CONCLUSIONS This investigation will evaluate the effects of Neuro Vision Technology therapy on compensatory vision rehabilitation. Additionally, quality of life and cognitive improvements associated to increased quality of life will be explored. CLINICALTRIAL ClinicalTrials.gov NCT03160131; https://clinicaltrials.gov/ct2/show/NCT03160131 (Archived by WebCite at http://www.webcitation.org/6x3f5HnCv)


Sign in / Sign up

Export Citation Format

Share Document